Tan, H P <br/><br/>
Two hundred living donor kidney transplantations under alemtuzumab induction and tacrolimus monotherapy: 3-year follow-up.  [electronic resource] 

 -  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons  Feb 2009 
 - 355-66 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1600-6143 
<br/><br/><label>Standard No.: </label>10.1111/j.1600-6143.2008.02492.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Alemtuzumab<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized<br/>Antibodies, Neoplasm--therapeutic use<br/>Antineoplastic Agents--therapeutic use<br/>Creatinine--analysis<br/>Female<br/>Follow-Up Studies<br/>Glomerular Filtration Rate<br/>Graft Rejection--epidemiology<br/>Graft Survival--physiology<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Infant<br/>Kidney Transplantation<br/>Laparoscopy<br/>Living Donors<br/>Male<br/>Middle Aged<br/>Nephrectomy<br/>Remission Induction<br/>Tacrolimus--therapeutic use<br/>Time Factors<br/>Transplantation Conditioning<br/>Treatment Outcome<br/>Young Adult